All posts by admin

Business Wire India

Nexthop AI, the leading pioneer of highly efficient AI Networking, today announced successful closure of an oversubscribed $500 Million Series B funding round, catapulting the company’s valuation to $4.2 Billion. This round was spearheaded by Lightspeed Venture Partners, with Andreessen Horowitz joining as a major investor, and participation from Altimeter and all existing investors.

 

“The rapid growth of AI is forcing a fundamental rethink of data center network architecture — and that creates one of the largest infrastructure market opportunities we’ve seen in a generation, with the potential to build a $100B+ company. That conviction led us to invest in Nexthop AI from Day One,” said Guru Chahal, Partner at Lightspeed Venture Partners. “Nexthop is uniquely positioned to become the next great networking vendor by combining hyperscale-grade performance, open software, and a co-development model built in lockstep with the world’s largest AI operators.“

 

 

“AI clusters are pushing data center networks to their limits, and networking is now central to overall system performance. Nexthop is purpose-built for this shift, combining deep hyperscale experience with a focus on high-performance and open networking,” said Raghu Raghuram, General Partner, Andreessen Horowitz. “We believe Anshul and the team are tackling one of the most important infrastructure challenges in AI today, and we’re excited to partner with them as they scale.”

 

 

Nexthop AI has quickly emerged as a frontrunner in the most advanced AI & Cloud Networking segment. The company delivers both off-the-shelf and highly customized switching solutions built on open source operating systems such as SONiC and FBOSS.

 

 

“Our relentless focus on innovation and deep customer partnerships has driven the development of highly customized JDM solutions for the largest operators and cutting-edge turnkey products for NeoClouds. We are thrilled to partner with the world’s leading investors in the AI space, to help scale the company to the next level,” said Anshul Sadana, Founder & CEO of Nexthop AI.

 

 

Today, Nexthop also launched a range of products for scale-out, scale-across and front-end applications for cloud and AI data centers. The launch portfolio sets new standards for performance, power efficiency, and deployment speed – very critical metrics in AI infrastructure.The company continues to invest in expanding R&D and infrastructure capabilities to broaden this foundational portfolio to meet the demands of unprecedented growth in infrastructure.

 

 

To learn more about today’s announcement, read the latest blog from Anshul Sadana, Founder & CEO of Nexthop AI.

 

 

Supporting Quotes

 

 

“AI datacenter networking is being rearchitected as genAI drives a new wave of infrastructure buildout by hyperscalers and neoclouds. With the market expected to reach $100B by 2031, there is significant opportunity for companies like Nexthop AI to deliver next-generation networking architectures with meaningful advantages in power and cost efficiency. These shifts toward scale-across networking will be critical in enabling the next generation of large-scale AI clusters while lowering total cost of ownership.” – Dylan Patel, Founder, SemiAnalysis.

 

 

About Nexthop AI

 

 

Nexthop AI is a cohesive team of seasoned industry experts, who through their collaborative product design as well as system and network engineering capabilities are building innovative networking products and solutions for Hyperscalers and NeoClouds. Nexthop is headquartered in Santa Clara with additional locations in Seattle, Vancouver, Dublin and Bengaluru, India. For more information visit http://nexthop.ai.

 

 

nexthop ai, the nexthop ai logo, and all related product and software names are trademarks of Nexthop Systems Inc. All other trademarks or service marks are the property of their respective owners. Product specifications and information are subject to change without notice.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310574112/en/

 

Business Wire India

Nexthop AI, the leading pioneer of highly efficient AI Networking, today launched a range of products for scale-out, scale-across and front-end applications for cloud and AI datacenters. The launch portfolio sets new standards for performance, power efficiency, and deployment speed – very critical metrics in AI infrastructure.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310990709/en/

 

 

 

Nexthop also unveiled the Disaggregated Spine architecture – a new, highly efficient, scale-across network design developed in collaboration with a large hyperscaler. This innovative architecture decomposes the traditional monolithic chassis running proprietary software into independent, optimized, functional tiers. It features a scale-across leaf tier (data center fabric facing) and scale-across spine tier (data center interconnect facing) offering deep buffers, line-rate MACsec encryption and expanded routing tables. This architecture delivers 30% lower cost and 30% lower power consumption than legacy chassis-based systems and facilitates adoption of open network operating systems such as SONiC.

 

Driving the Future of Open Networking

 

 

Nexthop AI is an active contributor to the open networking ecosystem, serving as a SONiC Governing Board member of the Linux Foundation. In a very short timeframe, Nexthop has risen to be amongst the top 10 global contributors to the SONiC project. Nexthop empowers customers to run their preferred version of a network operating system like SONiC or FBOSS on its switches. In addition, for the NeoClouds, Nexthop offers a hardened, supported, high-quality distribution of the Nexthop Network Operating System powered by SONiC.

 

 

“We are delighted to see the tremendous contributions Nexthop has made to the open networking community in such a short time. They are partnering with the community on several new initiatives, including pioneering new concepts like the Disaggregated Spine. Their speed of execution, coupled with their unwavering dedication to customer success, is truly commendable,” said Dave Maltz, Principal Network Architect for Azure Networking at Microsoft.

 

 

Pioneering New Platforms for AI and Cloud

 

 

Nexthop AI’s launch portfolio sets new standards for performance, power efficiency, and deployment speed – very critical metrics in AI infrastructure. These platforms can run any version of SONiC or FBOSS that hyperscalers choose or are also available as a turnkey solution fully integrated with Nexthop NOS for NeoClouds.

 

 

• NH-4010: The industry’s lowest power 51.2 Tbps switch based on Broadcom Tomahawk 5 silicon. Its highly efficient system design is proven to save customers 15-20% power in like-for-like configurations, delivering 10s of Megawatts of total power savings at scale.
• NH-4220: The industry’s highest density 102.4 Tbps air cooled system based on Broadcom Tomahawk 6 silicon. These switches are specifically engineered to provide seamless migration from previous generations without requiring disruptive changes to rack or fiber plants, enabling rapid deployment of next-generation AI clusters.
• NH-5010: The first deep-buffer, scale-across spine switch based on Broadcom Qumran 3D silicon, enabling the Disaggregated Spine architecture for leading Hyperscalers.

 

“We are pleased to collaborate with Nexthop on SONiC and SAI-based architectures to deliver standards-based Ethernet switching solutions for deployments within and across data centers, serving our hyperscale and data center customers. Nexthop’s deep system expertise and integration of our low-power switching silicon have enabled scalable, highly power-efficient solutions,” said Asad Khamisy, senior vice president and general manager, Core Switching Group, Broadcom.

 

Nexthop platforms offer advanced real-time telemetry for efficient congestion control, advanced load balancing and real-time layer 1 and optics monitoring – significantly improving overall network performance and link reliability.

 

 

“Ethernet Switching is a key building block for AI Networking. Led by new AI and scale-across use case expansions, the market is poised to approach $200B over the next decade,” said Alan Weckel, founder and technology analyst at 650 Group. “Nexthop AI is taking a unique co-development approach to product development and their initial platforms represent the start of a foundational portfolio that raises the bar to fundamentally address the efficiency, density, and reliability challenges to support 800G and 1.6T deployments.”

 

 

Availability and Additional Resources

 

 

Nexthop AI’s innovative platforms and software solutions are already shipping to leading Hyperscalers. Nexthop platforms also have a complementary optics portfolio with dedicated focus on Layer 1 validation that improves stability and deployment speed for customers.

 

 

To learn more about today’s announcements, explore the following resources:

 

 

1. The Hyperscaler Paradox – Build, Buy or Partner?, Anshul Sadana, Founder & CEO
2. Whitepaper – Disaggregated Spine for Modern AI Networks
3. Journey of a new company built for SONiC, Ryan Torres, VP Software Engineering

 

Our team will be at OFC 2026 in Los Angeles, demonstrating some of our AI solutions. To schedule a meeting with us, reach out to sales@nexthop.ai.

 

About Nexthop AI

 

 

Nexthop AI is a cohesive team of seasoned industry experts, who through their collaborative product design as well as system and network engineering capabilities are building innovative networking products and solutions for Hyperscalers and NeoClouds. Nexthop is headquartered in Santa Clara with additional locations in Seattle, Vancouver, Dublin and Bengaluru, India. For more information visit http://nexthop.ai

 

 

nexthop ai, the nexthop ai logo, and all related product and software names are trademarks of Nexthop Systems Inc. All other trademarks or service marks are the property of their respective owners. Product specifications and information are subject to change without notice.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310990709/en/

 

Business Wire India

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production and innovation capabilities to better support the continued growth of its Health & Biosciences (H&B) business in Latin America, one of the fastest-growing markets for the company. The effort includes the transformation of the Arroyito site in Argentina into IFF’s first full fermentation‑based enzyme production hub in the region and the opening of a household care application laboratory at IFF’s Innovation Center in Brazil. Together, these enhancements expand IFF’s regional footprint and are expected to improve speed, reliability and locally relevant solutions for markets including brewing, animal nutrition, biofuels and home care.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310253993/en/

 

 

 

“This is about turning science into impact where it matters most,” said Letícia Gonçalves, president of IFF H&B. “By bringing world‑class fermentation and application capabilities to Latin America, we are accelerating innovation for our customers and translating that into better food, more effective cleaning solutions and everyday products that improve quality of life for millions of consumers across the region.”

 

Building a regional enzyme production hub
IFF’s deep expertise in fermentation technology is at the heart of the Arroyito expansion, enabling the production of high‑performance enzymes through controlled biological processes that deliver consistent results under real‑world manufacturing conditions while reducing environmental impact. With the enhancements, IFF will now produce enzymes locally from the initial biological stage rather than relying solely on final processing and packaging steps, improving performance reliability, increasing processing efficiency and enabling faster adjustments as customer needs evolve across applications including brewing, animal nutrition, biofuels and home care.

 

 

Advancing applied innovation in home and personal Care
Complementing the Arroyito plant transformation, IFF’s new household care application laboratory in Brazil is designed to help customers evaluate and optimize enzyme performance under real regional conditions. The laboratory supports laundry and dishwashing applications, enabling faster testing, improved formulation accuracy and closer collaboration with customers developing next‑generation cleaning products.

 

 

“Latin America is a dynamic growth market for bioscience‑enabled solutions,” said Deia Vilela, vice president of Latin America for IFF H&B. “What’s most exciting is how this momentum is being shaped through deeper partnerships with customers and teams across the region, creating a strong foundation for sustained innovation and shared growth in the years ahead.”

 

 

Building on more than four decades of industrial biotechnology leadership, IFF’s investment reinforces its long‑term commitment to the region and positions its Health & Biosciences business to capture future growth across food, home and personal care, animal nutrition and bio‑industrial markets.

 

 

Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “”plan”, “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the new facilities. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

 

 

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

 

 

©2026 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ^SM or ^® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310253993/en/

 

Business Wire India

• ATLAS anchors H2O America’s equity raise and establishes new substantial shareholding
• Upsized transaction highlights strong market support for H2O’s long-term strategy and sector leading growth outlook
• H2O’s organic growth fully equity funded into 20281

 

ATLAS Infrastructure (“ATLAS”) is a specialist Global Listed Infrastructure investor managing funds on behalf of long-term infrastructure clients. Following the recent equity placement, ATLAS’s actively managed accounts hold ~10.8% voting and economic interest in H2O America (“H2O”).

 

ATLAS was pleased to support H2Os long‑term strategy to invest in local water and wastewater utility operations through our participation in the recent equity raise. ATLAS recognises the disciplined approach from H2O management which focuses on organic investment in existing businesses alongside targeted and accretive transactions such as the acquisition of Quadvest which materially expands H2O’s regulated water footprint in a premium high‑growth jurisdiction. The upsized equity raise, anchored by ATLAS, supports the company strategy through providing significant balance sheet capacity and financial flexibility well into the Company’s 2026-2030 CapEx plan.

 

 

“Increased investment in water utilities is essential to ensure that communities can continue to enjoy high quality drinking water and that wastewater networks can continue to improve to meet and exceed environmental expectations alongside a growing population. ATLAS is pleased to support the management and employees of H2O through this equity placement by ensuring that the company has the capital support to continue its strategy of investment and improvements to its network and services. This increased investment into H2O fits well with the ATLAS objective of delivering long term, sustainable returns for our clients through investment in high quality infrastructure companies that are investing in delivering essential services to their local communities.”
– Rod Chisholm, Partner

 

 

1. ATLAS estimates

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309037799/en/

 

Business Wire India

Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, today announced that its Cross-Border business has partnered with Formula E, the world’s first all-electric FIA World Championship and B Corp Certified sport. Under the agreement, Corpay becomes the exclusive and Official Foreign Exchange Provider of the ABB FIA Formula E World Championship.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310640540/en/

 

 

The ABB FIA Formula E World Championship brings dramatic racing to the heart of some of the world’s most iconic cities providing an elite motorsport platform for the world’s leading automotive manufacturers to accelerate electric vehicle innovation with the GEN3 Evo race continuing to set a new benchmark as the fastest-accelerating FIA single-seater, rocketing from 0-60 mph in an astonishing 1.82 seconds.

 

 

Through this partnership, Corpay Cross-Border will provide comprehensive FX risk management and international payment solutions to support Formula E’s global operations. With races spanning major cities across multiple continents, Formula E operates in a highly dynamic, multi-currency environment — creating a strong strategic fit for Corpay’s expertise in managing foreign exchange exposure and cross-border transactions.

 

 

“As a truly global motorsport platform, Formula E operates across numerous currencies and jurisdictions throughout its racing calendar,” said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “We are proud to partner with an innovative, forward-thinking championship and to support its international growth with tailored FX and cross-border payment solutions that help mitigate currency risk and drive operational efficiency.”

 

 

“Formula E is at the forefront of technology and sustainability, and it is vital that our partners reflect that same forward-thinking approach,” said Max Adkins, Chief Financial Officer, Formula E. “Partnering with Corpay allows us to streamline our global financial operations across a highly dynamic, multi-currency environment. We look forward to working together as we continue to bring the excitement of all-electric racing to fans around the world.”

 

 

About Corpay

 

 

Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Corpay’s suite of modern payment solutions help its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings) and payables (e.g. paying vendors). This results in our customers saving time and ultimately spending less. Corpay Cross-Border refers to a group of legal entities owned and operated by Corpay, Inc.

 

 

Corpay – Payments made easy. To learn more visit www.corpay.com.

 

 

About Formula E

 

 

The ABB FIA Formula E World Championship is known as the next evolution of motorsport. As the world’s first all-electric series, Formula E operates as a high-speed ‘living laboratory’ where innovation and adrenaline collide.

 

 

The championship has achieved the milestone of 150 races, and serves as a vital test bed for the world’s leading automotive manufacturers – including Porsche, Jaguar, Nissan, Stellantis, Mahindra and Lola Cars – to innovate and refine the electric vehicle (EV) technologies that will define future urban mobility.

 

 

Underpinning this performance is a profound commitment to impact. Formula E is a Certified B Corp – the world’s first and only sport to achieve this designation – reflecting its dedication to high standards of social and environmental transparency. It also stands as the only sport in the world to be Net Zero Carbon since inception and recently became the first to achieve the BSI Net Zero Pathway certification, setting a new global benchmark for science-based climate action.

 

 

As a progressive challenger in the sports landscape, Formula E is defined by unpredictable, wheel-to-wheel competition. In 11 seasons, the series has crowned 10 different champions, proving it to be one of the most competitive and open titles in world championship level sport. With a commitment to accessibility and a grid of world-class drivers and manufacturers, the series continues to rewrite the rules of elite sport, engaging a new generation who value purposeful ambition and fearless action.

 

 

www.FIAFormulaE.com

 

 

For Formula E media enquiries, please contact media@fiaformulae.com.

 

 

About ABB:

 

 

ABB is a global technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. By connecting its engineering and digitalization expertise, ABB helps industries run at high performance, while becoming more efficient, productive and sustainable so they outperform. At ABB, we call this ‘Engineered to Outrun’. The company has over 140 years of history and more than 110,000 employees worldwide. ABB’s shares are listed on the SIX Swiss Exchange (ABBN) and Nasdaq Stockholm (ABB). www.abb.com

 

 

*“Corpay” in this document primarily refers to the Cross-Border Division of Corpay, Inc. https://www.corpay.com/cross-border; a full listing of the companies that are part of Corpay Cross-Border is available here: https://www.corpay.com/compliance.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310640540/en/

 

Business Wire India

Forbes releases its 40th-annual World’s Billionaireslist, the definitive ranking of the planet’s richest people. Wealth surged to unprecedented levels over the past year, with fortunes climbing at a record pace. This year’s list features 3,428 billionaires, the most since the list’s inception in 1987. The world’s wealthiest people are worth a record $20.1 trillion combined, up from $16.1 trillion in 2025.

 

Elon Musktops the Billionaires list for the second year in a row and is the richest person ever recorded, worth an estimated $839 billion. His net worth skyrocketed by half of a trillion dollars from last year, thanks to a rise in the value of Tesla, and SpaceX which is aiming to go public in 2026. Musk is the first person ever recorded to reach the $800 billion mark, as he moves toward becoming the world’s first trillionaire.

 

 

“It’s the year of the billionaire,” said Chase Peterson-Withorn, Forbes Senior Editor, Wealth. “The planet added more than one billionaire per day over the past twelve months as the AI-powered stock market boom boosted fortunes to previously unimaginable heights.”

 

 

Larry Page, cofounder of Google, follows far behind Musk, in the No. 2 spot with an estimated net worth of $257 billion, followed by his cofounder Sergey Brin at No. 3 ($237 billion). Jeff Bezos holds the No. 4 spot ($224 billion) and Mark Zuckerberg ($222 billion) rounds out the top 5.

 

 

President Donald Trump’s fortune increased by 27%, to an estimated $6.5 billion, thanks largely to crypto dealings and his New York fraud penalty being thrown out. He ranks No. 645 worldwide.

 

 

The 2026 ranking features 390 newcomers, including Dr. Dre; Beyonce Knowles-Carter; and tennis legend Roger Federer.

 

 

The United States has more billionaires than any other country, now boasting a record 989.

 

 

For the full list, visit: www.forbes.com/billionaires.

 

 

About Forbes
Forbes is an iconic global media brand that has symbolized success for over a century. Fueled by journalism that informs and inspires, Forbes spotlights the doers and doings shaping industries, achieving success and making an impact on the world. The Forbes brand reaches more than 140 million people monthly worldwide through its trusted journalism, signature ForbesLive events and 49 licensed local editions in 81 countries.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310629058/en/

 

Business Wire India

• The bioenergy with carbon capture (BECCS) project aims to remove more than 500,000 tonnes per year of biogenic CO2 emissions from a U.S. paper mill’s recovery boiler
• Svante Development Inc. is co-investing to advance the project
• The project will generate high-quality carbon dioxide removal (CDR) credits to market to Voluntary Carbon Market (VCM) buyers.

 

Svante Technologies Inc. (“Svante”) announced today that its bioenergy with carbon capture and storage (BECCS) project at a paper mill in the Southeast U.S. has progressed to the feasibility study phase. The project is being developed in partnership with an integrated sustainable packaging company, following an extensive screening and pre-feasibility study conducted across several of the partner’s mills.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310319382/en/

 

 

 

During the feasibility study phase, the companies will complete further engineering and design activities, cost and schedule estimates, and risk assessments required to evaluate commercial viability ahead of a future engineering study leading to final investment decision (FID). Svante’s subsidiary, Svante Development Inc., is co-investing in this phase with the mill owner.

 

The project is designed to capture and permanently store more than 500,000 tonnes per year of biogenic CO₂ generated from mill operations. The biomass fiber used at the site is sourced from sustainably managed forests. The resulting carbon dioxide removal (CDR) credits will meet established monitoring, reporting, and verification (MRV) standards and are intended for sale to organizations aiming to address their Scope 1 and Scope 2 emissions.

 

 

“Advancing this work into feasibility provides the information we need to assess cost, project execution strategy, and plant integration requirements,” said Scott Gardner, President of Svante Development Inc. “It also aligns with progress on CO₂ storage infrastructure in the region, which is a necessary component of any integrated BECCS project.”

 

 

The project will leverage Svante’s advanced solid sorbent carbon capture and removal technology, which features rotary contactor machines and nanoengineered filters coated in solid sorbents designed to selectively capture CO₂ from post-combustion industrial flue gas.

 

 

Additional project design elements and considerations include:

 

 

• Waste heat and water recovery to reduce additional energy and water demand.
• Permanent, safe geologic CO₂ storage targeted within the U.S. Gulf Coast region, which has established Class VI permitting frameworks and suitable subsurface formations.
• Environmentally responsible CO₂ capture materials have zero secondary chemical emissions and are designed to be recyclable.

 

 

This project is one of several ongoing efforts by Svante in the pulp and paper sector to develop BECCS projects as a pathway for large‑scale biogenic carbon removal.

 

###

 

 

About Svante
Svante is an integrated carbon management company headquartered in Vancouver, Canada. The company makes nanoengineered filters and modular rotating contactor machines that capture and remove CO₂ in an environmentally responsible way from industrial emissions and the air. The company manufactures filters for direct air capture and other gas separations and develops carbon capture and storage projects from source to sink. The company is on the 2025 Global Cleantech 100 Hall of Fame and TIME & Statista’s list of Top Greentech Companies of 2025. For more information, visit www.svanteinc.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310319382/en/

 

Business Wire India

WHOOP, the human performance company, today unveiled multiple initiatives and new clinically-backed features, including the coming launch of the company’s Women’s Health Specialized Blood Biomarker Panel. Building on the WHOOP Advanced Labs Baseline Panel launched last year, the Women’s Health Specialized Blood Biomarker Panel adds 11 clinically backed, female-specific blood biomarkers that expand insight into areas that are frequently under-measured or misinterpreted in traditional women’s health testing. WHOOP has also announced a new Hormonal Symptom Insights and Predictions update, along with a comprehensive Menstrual Cycle White Paper detailing the science behind its cycle modeling.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310966566/en/

 

 

 

These initiatives reflect the company’s commitment to advancing women’s health in an area that has historically been under-researched and underrepresented in data, clinical standards, and performance science. Women represent a growing share of new WHOOP members, with 150% year-over-year growth, signaling increasing demand for health insights that account for hormonal dynamics, training response, and long-term health outcomes. Women also engage with WHOOP AI approximately 30% more than male members, reflecting strong demand for intelligent, personalized women’s health support.

 

“Unlike solutions that focus on isolated conditions or single life stages, WHOOP delivers a connected health experience informed by one of the world’s largest datasets on women’s physiology,” said Alex Vannoni, Head of Healthcare Product at WHOOP. “We’re not just helping women track their cycles. We’re helping them understand how their physiology evolves over time – and giving them tools to act on it.”

 

 

WHOOP Advanced Labs: Women’s Health Specialized Panel

 

 

The Advanced Labs baseline and new Women’s Health Specialized Panel create a progressive, female-first testing pathway that supports women across all life stages.

 

 

The new panel, launching next month, includes critical biomarkers that dive deeper into cycle regulation and hormonal transitions, including perimenopause, thyroid function, nutrient sufficiency, and bone–metabolic resilience. The biomarkers tested are: Anti-Müllerian Hormone (AMH), Progesterone, Prolactin and Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12 (Cobalamin), Folate, Magnesium and Phosphate (as Phosphorus).

 

 

By layering lab data on top of continuous wearable metrics and AI-modelling, WHOOP enables members to see how biomarkers correlate with recovery trends, strain tolerance, sleep efficiency, and stress patterns over time – turning static lab results into dynamic insight.

 

 

Members will be able to purchase the Women’s Health Specialized Panel via the WHOOP app.

 

 

Hormonal Symptom Insights and Predictions

 

 

WHOOP is also expanding its Menstrual Cycle Insights and Pregnancy Insights offering, with a new update – Hormonal Symptom Insights and Predictions. Within the WHOOP app, menstruating members will now receive a personalized model of their cycle that adapts over time, based on their unique physiological data and historical patterns.

 

 

Within the WHOOP app, members will now have access to key data about their cycle that allows them to accurately adjust their daily routines, fitness regimes, and recovery practices and anticipate potential symptoms rather than simply recording them. This includes access to:

 

 

• A dynamic date window for the next period, allowing for more anticipation around the menstrual cycle
• Tracked trends in cycle length, period length, and variability, flagging irregular patterns before larger issues persist
• Analyzed individual symptom patterns to anticipate when symptoms are most likely to occur

 

As part of the latest Cycle Insights updates, the feature now integrates with WHOOP Advanced Labs. This integration enables WHOOP to deliver personalized biomarker ranges – categorized as ‘optimal,’ ‘sufficient,’ or ‘out of range’ – based on where a member is in their cycle. When a member completes a blood draw, WHOOP automatically applies the appropriate reference range aligned to their recorded cycle phase, ensuring results are interpreted through the lens of their physiology. It’s another example of how women’s unique biology is embedded into every WHOOP product and feature.

 

Menstrual Cycle White Paper

 

 

WHOOP has also published a comprehensive Menstrual Cycle White Paper outlining the research, methodology, and validation behind its modeling approach. The white paper proves how continuous physiological monitoring improves prediction accuracy over time, how the system accounts for variable cycles, perimenopause, and hormonal birth control, and how prediction windows dynamically widen or narrow based on variability.

 

 

By bringing continuous, longitudinal visibility to cycle patterns, WHOOP aims to increase health literacy and close a long-standing data gap in women’s health.

 

 

“What makes this powerful isn’t any single data point – it’s how the system comes together,” said Emily Capodillupo, Senior Vice President of Research, Algorithms, and Data at WHOOP. “Women don’t experience their physiology in silos. Hormones influence sleep, sleep affects recovery, and recovery shapes training response. By modeling these interactions over time – across continuous biometrics, lab data, and behavior – we can deliver guidance that reflects the full system, not just a snapshot.”

 

 

With the support of the WHOOP Medical Advisory Board, including Dr. Robin Berzin and Dr. Hazel Wallace, and in tandem with their recent collaboration with Clue, a leader in menstrual and reproductive health, WHOOP will continue to drive innovation in women’s health and deliver on the company’s goal of adding one billion healthy years to the planet.

 

 

The Women’s Health Specialized Panel, along with additional blood panels, will be available via WHOOP in April. You can find links to imagery in our Digital Press Kit.

 

 

*The Women’s Health Specialized Panel will be available exclusively in the US at launch.

 

 

About WHOOP:

 

 

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and long-term wellbeing. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Peer-reviewed research shows: that members who wear WHOOP daily increase their weekly exercise by more than 90 minutes, gain over two hours of additional sleep per week, and improve heart rate variability by 10%.

 

 

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $400 million in venture capital, ships to 56 countries, and operates in six languages. Learn more at whoop.com and connect with WHOOP on Instagram, LinkedIn, X, Facebook, and YouTube.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310966566/en/

 

Business Wire India

 

Worldwide shipments of desktops, notebooks and workstations in 2026 are expected to decline by 12% to 245 million units, according to the latest outlook from Omdia. This forecast is grounded in sharp increases in memory and storage prices – particularly the expected minimum 60% rise in 1Q26. Further upward price pressure is anticipated throughout the remaining quarters of the year, though subsequent increases are expected to be more moderate. Since 1Q25, the costs of mainstream memory and storage configurations have risen by between US$90 and US$165, placing substantial financial pressure on PC vendors and forcing them to reduce promotions, raise product prices, and adjust configurations. The impact across PC product categories is expected to be broadly consistent. Desktops are set to decline by 10% to 53.2 million units, while laptops will decline by 12% to 192.2 million units.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310225638/en/

 

 

 

Considering how quickly the situation is evolving, Omdia has conducted a multi-scenario analysis of the impact. Based on the latest available information and market signals, the forecast carries a higher downside risk, namely a widening of shortages for both memory and storage and increasingly steep price hikes. This could further suppress consumer demand and tighten PC vendors’ supply, pushing PC shipments toward a 15% decline or potentially worse. In addition, the recent outbreak of conflict in the Middle East has introduced substantial uncertainty for international transportation and regional market growth, although it remains to be seen whether this situation will persist.

 

Further analysis by price band shows that shortages and price increases have affected products across different price tiers to varying degrees. “For lower-priced products, there is less margin room to absorb rising costs, and consumers in this segment are typically more sensitive to price fluctuations,” said Omdia Principal Analyst Ben Yeh. “In addition, lower-price-band products often rely on lower-capacity, previous-generation components and receive lower allocation priority while facing the hurdle of some suppliers discontinuing production. Within the limited bit supply PC vendors could obtain, prioritizing premium products will be a preferred strategy to mitigate impacts to business performance.”

 

 

In 2026, PCs priced below US$500 are expected to be hit hardest, declining by 28% to around 62.1 million units shipped. By contrast, shipments of high-end PCs priced at US$900 and above are better supported and may even maintain modest growth. “Beyond the stronger ability of higher price bands to absorb cost increases, we also factored in that some consumers and IT decision makers will accept higher price points to meet essential needs, which will drive an upward shift in the price mix,” Yeh added. “However, the movement toward higher price bands does not necessarily represent improved product configurations.”

 

 

Worldwide desktop and notebook shipments (market share and annual growth)   Omdia PC Forecast: 2025 and 2026
Platform	2025 shipments	2025 market share	2026 forecast	2026 market share	Annual growth
Windows & Others	231,679	83.1%	203,550	83.0%	-12.1%
MacOS	27,740	10.0%	26,401	10.8%	-4.8%
ChromeOS	19,317	6.9%	13,990	5.7%	-27.6%
HarmonyOS	141	0.1%	1,404	0.6%	897.0%
Total	278,876	100.0%	245,344	100.0%	-12.0%
Note: Unit shipments in thousands. Percentages may not add up to 100% due to rounding.   Source: Omdia PC Horizon Service (sell-in shipments and forecast), March 2026

 

 

“The supply-driven downturn in 2026 will not affect all PC platforms equally,” said Kieren Jessop, Research Manager at Omdia. “Windows PCs, which account for 83% of shipments, are forecast to decline 12% in 2026 as the platform bears the brunt of memory and storage constraints. Chrome devices face the steepest decline at 28%, as the education-heavy platform is particularly exposed to tighter component allocation, lower margins and the discontinuation of some memory and storage products. Macs are set for a comparatively modest 5% decline, supported by Apple’s vertically integrated supply chain and premium positioning. Meanwhile, HarmonyOS-based PCs are emerging as a notable growth segment, forecast to expand tenfold year on year from a small base as Huawei ramps up its PC ecosystem in China.”

 

ABOUT OMDIA

 

 

Omdia, part of TechTarget, Inc. d/b/a Informa TechTarget (Nasdaq: TTGT), is a technology research and advisory group. Our deep knowledge of tech markets grounded in real conversations with industry leaders and hundreds of thousands of data points, make our market intelligence our clients’ strategic advantage. From R&D to ROI, we identify the greatest opportunities and move the industry forward.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310225638/en/

 

Business Wire India

• Ferring’s total revenues for 2025 exceeded €2.5 billion, an increase of 10% from 2024, mainly driven by our flagship product Menopur®
• Continued ramp-up in the US for Adstiladrin®, our novel gene-based therapy for bladder cancer, confirming its position as Ferring’s second major growth driver
• Commitment to sustainability demonstrated by SBTi approval of our targets to reduce greenhouse gas emissions, and by our programme to reduce maternal deaths in low- and lower middle-income countries

 

Ferring today published its 2025 Annual Report and Sustainability Report. The company achieved total revenues of over €2.5 billion in 2025, an increase of 7% over the previous year at actual exchange rates (AER) and 10% at constant exchange rates (CER). These were mainly driven by our flagship product Menopur^® (menotropins for injection) in reproductive medicine, and the ramp-up in the US of our breakthrough gene-based therapy for non-muscle invasive bladder cancer, Adstiladrin^® (nadofaragene firadenovec-vncg).

 

Operating expenses were contained to an increase of €61 million year-on-year (i.e. +5% at AER and +7% at CER), and this includes significant non-recurring items (notably impairment charges and restructuring provisions). Underlying operating expenses remained well-controlled, with increased investments targeted to support the growth of Adstiladrin and other opportunities. Thus, operating profit for the year reached €167 million, a decrease of -€24 million (‑13%) versus the prior year at AER, while remaining flat at CER – with the difference being driven by the weaker US dollar.

 

 

Following a focus on improving cash conversion after several heavy investments, free cash flow generation approached neutral despite currency headwinds from the weaker US dollar. This represents a substantial improvement compared to the previous year, and a significant step towards sustainable cash generation.

 

 

Jean-Frédéric Paulsen, Chairman of the Board of Directors and Chief Executive Officer, said: “This was a pivotal year as we continued evolving our business to become stronger, more agile and more resilient, and importantly we got back to free cash flow neutral. Moreover, in 2025, we introduced an enterprise model designed to create greater value for patients and customers while supporting sustainable growth. This reflects our long-term commitment to serving patients’ need, and fostering an environment where people can learn, grow and perform at their best.”

 

 

Ferring has always conducted business responsibly by seeking to protect the environment, create value for society, and uphold our high standards of ethics and governance. In 2025, we passed a major milestone when our targets for reducing greenhouse gas (GHG) emissions were approved by the Science Based Targets initiative (SBTi). This globally recognised standard ensures corporate goals are aligned with international climate policy. During the year, we succeeded in reducing our Scope 1 and 2 GHG emissions by 4.3% and Scope 3 emissions by 19%.

 

 

Access to affordable healthcare is embedded in Ferring’s purpose and strategic priorities. The Project Family™: Safe Birth initiative aims to reduce maternal deaths in low- and lower middle-income countries by enabling wider access to Carbetocin Ferring (carbetocin, room-temperature stable formulation). In 2025, we worked with partners to supply around 1.7 million doses of this life-saving medicine at an affordable access price, while gaining further approvals in seven low- and lower middle-income countries.

 

 

About Ferring Pharmaceuticals

 

 

Ferring Pharmaceuticals is a privately owned specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine with a strong heritage in gastroenterology and urology and are at the forefront of innovation in uro-oncology gene therapy. Ferring was founded in 1950 and employs more than 7,500 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which market its medicines in over 100 countries.

 

 

Learn more at www.ferring.com, or connect with us on LinkedIn, Instagram and YouTube.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310378948/en/